Methoxsalen is a medicine used to treat skin conditions like psoriasis and eczema. It works by making your skin more sensitive to sunlight, which helps reduce the symptoms. It's usually taken with special light therapy.
Every report comes from a Lived member, sent anonymously.
Have you tried Methoxsalen for Psoriasis?
Methoxsalen is a prescription medicine that makes the skin temporarily far more sensitive to ultraviolet A (UVA) light. On its own it does little; its purpose is to be paired with carefully measured doses of UVA from a medical light cabinet. Methoxsalen belongs to a family of light-sensitizing compounds called psoralens, and the combination of a psoralen plus UVA is called PUVA, or photochemotherapy. In the US, oral methoxsalen capsules are approved for severe, disabling psoriasis that has not responded well enough to other treatments, once the diagnosis has been confirmed. The fast-absorbing soft capsule is known by the brand name Oxsoralen-Ultra and is available as generic methoxsalen capsules; the older hard capsule, 8-MOP, has been discontinued. Dermatologists also use PUVA for some other skin conditions, such as vitiligo and early cutaneous T-cell lymphoma (a lymphoma that starts in the skin), usually after narrowband UVB, a light treatment that needs no drug, has not worked well enough. A separate product, Uvadex, uses methoxsalen in a different way. It is never given to the patient directly. During a procedure called photopheresis, some of the person's white blood cells are collected by a machine, treated with Uvadex and UVA light, and returned. Uvadex is approved for the skin effects of cutaneous T-cell lymphoma that have not responded to other treatment. Most of this page describes oral PUVA.
Taken by mouth, methoxsalen travels through the bloodstream into the skin. It does nothing much until UVA light reaches it. The light activates the drug, which then binds to the DNA inside skin cells. In psoriasis, skin cells multiply far faster than normal and build up into thick, scaly plaques. The light-activated drug slows that excessive cell growth and also dampens some of the immune activity driving the inflammation. Researchers do not fully understand which of these effects matters most. The same reaction explains the main side effects: a delayed, sunburn-like redness, tanning, and with many treatments over years, skin aging and a higher risk of skin cancer.
Oral PUVA is given in a dermatology office or phototherapy center. The capsules are taken at home with some low-fat food or milk, timed so the drug peaks in the skin during the light session (for the soft capsules, usually about 1.5 to 2 hours beforehand). The dose is based on body weight, and the light dose is set by skin type and adjusted at every visit according to how the skin reacted last time. Sessions are typically two or three times a week and never on consecutive days, because a burn may not show its full extent until about 48 hours later. The soft capsules are absorbed faster and more completely than the older hard capsules, so the timing and light doses for one form should not be applied to the other. Protection after each dose is part of the treatment. Wear wraparound sunglasses that block UVA for 24 hours after taking the capsules whenever daylight is present, including indoors near windows; ordinary sunglasses are not enough. Keep skin and lips out of the sun for at least 8 hours afterward, even through window glass or cloud cover, using clothing, a hat and sunscreen. Avoid sunbathing the day before a session and for 48 hours after one. If extra capsules are taken by mistake, stay out of daylight and call Poison Control at 1-800-222-1222 or the prescriber right away.
Nausea is the most common effect of the capsules themselves, affecting about 1 in 10 people. Taking them with food or milk often helps. Itching is also common and usually responds to moisturizers. Most people develop a tan during treatment, which fades over the weeks after stopping. Dizziness, headache, nervousness, trouble sleeping and low mood are less common. Redness after PUVA behaves differently from an ordinary sunburn. It appears late, often peaking 48 to 72 hours after a session, so the skin can look fine the evening after treatment and worsen over the next two days. Mild pinkness is expected. Painful, spreading or blistering redness, especially redness that is already strong within a day of treatment, can signal a severe burn; contact the treatment team promptly and stay out of the sun, since another session may need to be skipped or the area shielded. Contact the team too if nausea, itching or another side effect is still bothering you 24 to 48 hours later.
Methoxsalen carries an FDA boxed warning because PUVA can damage the eyes, age the skin and cause skin cancer, including melanoma. The risk of squamous cell skin cancer rises with the total number of treatments and is higher in people with fair skin that burns easily, and in those who have had X-ray treatment of the skin, arsenic or extensive coal tar and UVB treatment. For this reason, PUVA is supervised by dermatologists experienced in phototherapy and is usually not the first light treatment tried. Methoxsalen is not used in people who have had melanoma or invasive squamous cell skin cancer, who have no natural lens in an eye (aphakia, which raises the risk of retinal damage), who have reacted badly to psoralens before, or who have light-sensitive diseases such as lupus or porphyria, except in special circumstances. Liver disease, heart conditions and prior cataracts call for extra caution. Many common medicines also make skin more sensitive to light and can turn a planned dose into a burn. These include tetracycline and fluoroquinolone antibiotics (such as doxycycline and ciprofloxacin), sulfa drugs, thiazide diuretics (water pills for blood pressure), some antipsychotic medicines, the antifungal griseofulvin, and coal tar products. Tell the team about every prescription, supplement and skin product, including new ones started partway through treatment. It is not known whether PUVA harms a developing baby, and methoxsalen has caused fetal harm in animal studies, so people who could become pregnant are advised to use contraception and to tell the team promptly if they become pregnant. Breastfeeding is not recommended during treatment. Safety in children has not been established, and phototherapy without a drug is usually preferred for them.
Psoriasis usually starts to improve over the first several weeks, and clearing usually takes about 25 to 30 sessions, or roughly 9 to 15 weeks, though this varies from person to person. In studies, roughly 8 in 10 people with psoriasis see it improve by three quarters or more. After that, sessions may be spaced out to weekly or less, and some people stop and restart if psoriasis returns. Because each session adds to long-term skin cancer risk, the team generally aims for the fewest treatments that keep the skin under control. Monitoring continues alongside treatment. An eye examination is recommended before starting and regularly afterward. The skin cancer risk does not end when treatment stops: melanoma has appeared in some people years after their last session. Regular skin checks by a clinician and by yourself are worth keeping up for life, and a new or changing growth, or a sore that does not heal, should be reported to a doctor. Photopheresis with Uvadex follows its own schedule, typically two consecutive days every four weeks for at least six months. The most common problem during the procedure is a drop in blood pressure as blood moves through the machine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Methoxsalen, what you've noticed, or ask the community a question.